Drug Profile
Middle East respiratory syndrome coronavirus vaccine - GeneOne Life Sciences/Inovio Pharmaceuticals
Alternative Names: GLS 5300; INO-4301; INO-4700; MERS vaccine - GeneOne Life Sciences/Inovio PharmaceuticalsLatest Information Update: 22 Nov 2022
Price :
$50
*
At a glance
- Originator Inovio Pharmaceuticals
- Developer GeneOne Life Science; Inovio Pharmaceuticals; Walter Reed Army Institute of Research
- Class Antivirals; DNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Middle East respiratory syndrome coronavirus
Most Recent Events
- 17 Nov 2022 Discontinued - Phase-I for Middle East respiratory syndrome coronavirus (Prevention) in USA (IM)
- 17 Nov 2022 Discontinued - Phase-I/II for Middle East respiratory syndrome coronavirus (Prevention) in South Korea (Intradermal)
- 17 Nov 2022 Discontinued - Phase-II for Middle East respiratory syndrome coronavirus (Prevention) in Lebanon, Kenya, Jordan (Intradermal)